Pierre Hainaut

45.2k citations

411 papers · 30.2k indexed · 7 hit papers · h-index 84

Molecular Biology top 0.1%
Oncology top 0.05%
Cancer Research top 0.05%
Pulmonary and Respiratory Medicine top 0.2%
Epidemiology top 0.5%

Co-authors: Magali Olivier Monica Hollstein Amina Amadou Amelie Plymoth Lewis R. Roberts Ju Dong Yang Gregory J. Gores Audrey Petitjean
Topics: Cancer-related Molecular Pathways (167 papers)Cancer Genomics and Diagnostics (58 papers)Epigenetics and DNA Methylation (56 papers)
Cited by: Cancer Research Oncology Hepatology
Journals: Proceedings of the National Academy of Sciences The Lancet Nucleic Acids Research
Partner nations: France United States United Kingdom

In The Last Decade

Pierre Hainaut

402 papers receiving 29.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A global view of hepatocellular carcinoma: trends, risk, prevention and management

2019 2.9k citations Ju Dong Yang, Pierre Hainaut et al. Nature Reviews Gastroenterology & Hepatology profile →
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use

2009 1.5k citations Magali Olivier, Monica Hollstein et al. profile →
Impact of mutant p53 functional properties onTP53mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

2007 1.2k citations Pierre Hainaut, Magali Olivier et al. Human Mutation profile →
The IARC TP53 database: New online mutation analysis and recommendations to users

2002 980 citations Magali Olivier, Monica Hollstein et al. Human Mutation profile →
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers

2002 815 citations Magali Olivier, Pierre Hainaut et al. profile →
p53 and Human Cancer: The First Ten Thousand Mutations

1999 788 citations Pierre Hainaut, Monica Hollstein profile →
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

2007 689 citations Maria Isabel Achatz, Pierre Hainaut et al. profile →

Peers

Countries citing papers authored by Pierre Hainaut

Since Specialization

Citations

This map shows the geographic impact of Pierre Hainaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Hainaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Hainaut more than expected).

Fields of papers citing papers by Pierre Hainaut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Hainaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Hainaut. The network helps show where Pierre Hainaut may publish in the future.

Co-authorship network of co-authors of Pierre Hainaut

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Hainaut. A scholar is included among the top collaborators of Pierre Hainaut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Hainaut. Pierre Hainaut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent 2023 ·Cell Death and Differentiation ·Arnold J. Levine,John D. Carpten,Maureen E. Murphy,Pierre Hainaut	3
2	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk 2022 ·Cancer Discovery ·(unknown),Simone Hausmann,Gaël S. Roth,Clément Oyeniran,Tanveer Ahmad,(unknown),Joshua R. Brickner,(unknown),Florent Chuffart,(unknown),(unknown),(unknown),Marianne Tardif,Pascal W.T.C. Jansen,Yohann Couté,Michiel Vermeulen,Pierre Hainaut,Paweł K. Mazur,Nima Mosammaparast,Nicolas Reynoird	18
3	The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute 2022 ·Cell Death and Differentiation ·Kelvin C. de Andrade,(unknown),(unknown),Chimene Kesserwan,James J. Manfredi,(unknown),(unknown),Jiří Zavadil,Lei Zhou,Magali Olivier,Megan N. Frone,(unknown),William J.R. Longabaugh,Christian P. Kratz,David Malkin,Pierre Hainaut,Sharon A. Savage	80
4	A global view of hepatocellular carcinoma: trends, risk, prevention and managementbreakdown → 2019 ·Nature Reviews Gastroenterology & Hepatology ·Ju Dong Yang,Pierre Hainaut,Gregory J. Gores,Amina Amadou,Amelie Plymoth,Lewis R. Roberts	2931
5	Higher-than-expected population prevalence of potentially pathogenic germlineTP53variants in individuals unselected for cancer history 2017 ·Human Mutation ·Kelvin C. de Andrade,(unknown),Douglas R. Stewart,Eric Karlins,Roelof Koster,Mingyi Wang,Susan M. Gapstur,Mia M. Gaudet,Neal D. Freedman,Maria Teresa Landi,Nicolas Lemonnier,Pierre Hainaut,Sharon A. Savage,Maria Isabel Achatz	36
6	Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity 2014 ·Clinical Cancer Research ·(unknown),Julien Laffaire,Sylvie Lantuéjoul,Denis Moro‐Sibilot,(unknown),François Arbib,Anne‐Claire Toffart,Fabien Petel,Pierre Hainaut,Sophie Rousseaux,Saadi Khochbin,Aurélien de Reyniès,Élisabeth Brambilla	32
7	Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐analysis of Randomized Controlled Trials 2014 ·Journal of the American Heart Association ·Jonathan Douxfils,Fanny Buckinx,François Mullier,Valentine Minet,Véronique Rabenda,Jean‐Yves Reginster,Pierre Hainaut,Olivier Bruyère,Jean‐Michel Dogné	77
8	Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures 2013 ·Carcinogenesis ·Corinne Sagné,Virginie Marcel,Maria Bota,Ghyslaine Martel‐Planche,Alberto Nóbrega,Edenir Inêz Palmero,(unknown),Mathieu Boniol,Stéphan Vagner,David G. Cox,C. Savio Chan,Jean‐Louis Mergny,Magali Olivier,Patrícia Ashton‐Prolla,J. Hall,Pierre Hainaut,Maria Isabel Achatz	30
9	An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial 2012 ·Clinical Cancer Research ·Florence de Fraipont,Guénaëlle Levallet,Christian Créveuil,Emmanuel Bergot,Michèle Beau‐Faller,Mounia Mounawar,Nicolas Richard,Martine Antoine,Isabelle Rouquette,Marie‐Christine Favrot,D. Debieuvre,Denis Braun,Virginie Westeel,Élisabeth Quoix,Élisabeth Brambilla,Pierre Hainaut,Denis Moro‐Sibilot,Franck Morin,B. Milleron,Gérard Zalcman	46
10	International Efforts to Develop Biospecimen Best Practices 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Jimmie B. Vaught,Élodie Caboux,Pierre Hainaut	38
11	Aberrant DNA Methylation Links Cancer Susceptibility Locus 15q25.1 to Apoptotic Regulation and Lung Cancer 2010 ·Cancer Research ·Anupam Paliwal,Thomas Vaissière,Annette M. Krais,Cyrille Cuenin,Marie‐Pierre Cros,David Zaridze,Anush Moukeria,P. Boffetta,Pierre Hainaut,Paul Brennan,Zdenko Herceg	53
12	MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma 2010 ·Cancer Research ·Johannes Voortman,Akiteru Goto,Jean Mendiboure,Jane J. Sohn,Aaron J. Schetter,Motonobu Saito,Ariane Dunant,Trung C. Pham,Iacopo Petrini,(unknown),Khan Ma,Pierre Hainaut,Jean‐Pierre Pignon,Élisabeth Brambilla,Helmut Popper,Martin Filipits,Curtis C. Harris,Giuseppe Giaccone	109
13	Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors 2008 ·Cancer Research ·Thomas Vaissière,Rayjean J. Hung,Давид Заридзе,Anush Moukeria,Cyrille Cuenin,(unknown),Gilles Ferro,Anupam Paliwal,Pierre Hainaut,Paul Brennan,Jörg Tost,Paolo Boffetta,Zdenko Herceg	207
14	Patterns of EGFR, HER2, TP53 , and KRAS Mutations of p14arf Expression in Non–Small Cell Lung Cancers in Relation to Smoking History 2007 ·Cancer Research ·Mounia Mounawar,Anush Mukeria,Florence Le Calvez‐Kelm,Rayjean J. Hung,Hélène Renard,Alexis B. Cortot,(unknown),Давид Заридзе,Paul Brennan,Paolo Boffetta,Élisabeth Brambilla,Pierre Hainaut	83
15	The Gambia hepatitis intervention study (GHIS) 2007 ·SHILAP Revista de lepidopterología ·Pierre Hainaut	1
16	Hepatitis infections, aflatoxin and hepatocellular carcinoma 2007 ·SHILAP Revista de lepidopterología ·Pierre Hainaut	2
17	Liver cancer prevention in The Gambia, West Africa. 2006 ·Cancer Epidemiology and Prevention Biomarkers ·Ebrima Bah,Pierre Hainaut	0
18	TP53 and KRAS Mutation Load and Types in Lung Cancers in Relation to Tobacco Smoke: Distinct Patterns in Never, Former, and Current Smokers 2005 ·Cancer Research ·Florence Le Calvez‐Kelm,Anush Mukeria,Jay D. Hunt,(unknown),Rayjean J. Hung,Philippe Tanière,Paul Brennan,Paolo Boffetta,Давид Заридзе,Pierre Hainaut	207
19	Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas 1996 ·International Journal of Cancer ·Asunción Esteve,Ghyslaine Martel‐Planche,Bakary S. Sylla,Monica Hollstein,Pierre Hainaut,Ruggero Montesano	3
20	Low frequency ofp16/CDKN2 gene mutations in esophageal carcinomas 1996 ·International Journal of Cancer ·Asunción Esteve,Ghyslaine Martel‐Planche,Bakary S. Sylla,Monica Hollstein,Pierre Hainaut,Ruggero Montesano	39

About Pierre Hainaut

Pierre Hainaut is a scholar working on Oncology, Cancer Research and Internal Medicine, having authored 411 papers that have together received 30.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (167 papers), Cancer Genomics and Diagnostics (58 papers) and Epigenetics and DNA Methylation (56 papers). The work is most often cited by research in Cancer Research (8.3k citations), Oncology (12.4k citations) and Hepatology (2.2k citations). Pierre Hainaut has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Magali Olivier, Monica Hollstein, Amina Amadou, Amelie Plymoth, Lewis R. Roberts, Ju Dong Yang, Gregory J. Gores, Audrey Petitjean, J Milner and Gerd P. Pfeifer. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact